The goal of the Burkitt Lymphoma Genome Sequencing Project (BLGSP) is to explore potential genetic changes in patients with Burkitt lymphoma (BL)Opens in a New Tab that could lead to better prevention, detection, and treatment of this rare and aggressive cancer.
Projects
HIV-Associated Cancers
The Office of Cancer Genomics (OCG)Opens in a New Tab, along with the Office of HIV and AIDS Malignancies (OHAM)Opens in a New Tab, initiated the HIV+ Tumor Molecular Characterization Project (HTMCP) to gain insight into the genetic events driving HIV-associated cancers and to determine why certain cancers, but not others, have higher incidences in HIV-positive patients.
Medulloblastoma
CGCI developed the Medulloblastoma Project to apply newly emerging genomic methods towards the discovery of novel genetic alterations in medulloblastoma (MB)Opens in a New Tab.
Non-Hodgkin Lymphoma
CGCI initiated the Non-Hodgkin Lymphoma Project to elucidate the mutation spectrums of the two most abundant forms of non-Hodgkin lymphoma (NHL)Opens in a New Tab: follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL).